{"id":64287,"date":"2025-02-04T00:01:33","date_gmt":"2025-02-04T00:01:33","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/04\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/"},"modified":"2025-02-04T00:01:33","modified_gmt":"2025-02-04T00:01:33","slug":"praxis-precision-medicines-to-present-at-two-february-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/","title":{"rendered":"Praxis Precision Medicines to Present at Two February Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"left\">BOSTON, Feb.  03, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HtuJpFgGMieM0o_2nXmdoW_H4cvmDAq2af_H9YwDeraIteZQef_NQjHT-F7JIGFtS2zVUkdZHQ_RS5osF3RKWsTKv33kKkthxXY0osqUmUQ=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>Praxis Precision Medicines<\/u><\/a>, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in two upcoming investor conferences:<\/p>\n<ul type=\"square\">\n<li>Praxis management will be participating in a fireside chat at the <strong>Guggenheim Securities SMID Cap Biotechnology Conference<\/strong>, taking place in New York City on February 6, 2025, at 2:30 p.m. EST. A live webcast of the event will be available through this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mDK6MtJ_Z1g7TXUxt6vs2rsMyLRM7vsMmNJ4ajuWeUB7LNJ00IwcICw15cQ5NBplf-rPNC2TGae4V5bCNRH7wm_eE3jsQGUG8lEEOLls8lpgxupyenoigA2AFk3z3YrnZrxPf9zXosmHiPMIEyIHr8GtjY8addD4DKWPxkmSZNGTtVPlGcD6J2XrBToB8RwXFc8ZEsIVxWYzAY3haDaPNKGjMeSM3EZXBWGcEMjvA5C738rJ8PoIdiaoeijbnwe_yAEe-F4mZWCRT8Zkjad-qtXiHlz5unnNsITmePFfOBv14uhrqHRG3js4YrSdX3gCRaNXG6_wbkpLFYeVhLZXO4HybuqDBdXFcvCQl8cpJjXDEsAV-sWVbcJMplBoBfckr4W0PHel3i76EMoOzOU6MEfo74PLDG_GtA1gwUGdVjZyIdjAqe5SAGddIH3F4xhCRgg6YbjxEEvUSOEf63RONPkGWT3lIgtrVYgYnEo5Etz9b2mZb5ENRS-O6yRlzHPvexHOM91iSgQWNRc2mJ6BoRed5JQxivLpLcHgJxw5V92o5Q4uEePbKwbocjwSZCl5Mv0BiHM1HTnBGKpj5y532q5dok-lddfr4dZ6Zu7PPsRtMd01AEZD65pRQJ1M4ms9HlFNwoUWTqfk6AAWDy4Evg==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>link<\/strong><\/a>.<\/li>\n<li>Praxis management will also be participating in a fireside chat at the <strong>Oppenheimer 35<\/strong><sup><strong>th<\/strong><\/sup><strong> Annual Healthcare Life Sciences Conference<\/strong>, taking place virtually on February 11, 2025, at 11:20 a.m. EST. A live webcast of the event will be available through this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mDK6MtJ_Z1g7TXUxt6vs2rsMyLRM7vsMmNJ4ajuWeUAg7bw5sXUN3Z8gAsBi-qIePp3FRY1BKBwgkKEJEV6XxrLWP4JixkD66IAMG1KyWkxvlyTbDqOHwVuxiFqc-vZ4\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>link<\/strong><\/a>.<\/li>\n<\/ul>\n<p>The Company will be available for one-on-one meetings during both conferences. Interested investors should contact their respective Guggenheim and\/or Oppenheimer representatives to request meetings.<\/p>\n<p>Both webcasts will also be available on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2_PUp5DL8ZYUUGJT6YGhRMEjaLybrk9crhIYjRZorhlKwJ_ZRRMFRXeTcwXrlrcB3jTDEwyrmG8t9YZ-5DdpFIb77mtKoN1C-DnFYGc9hTnmFdFH1kAd1PMaYKOa2xww05nRPtNGjMOb3Ybse9sdeA==\" rel=\"nofollow\" target=\"_blank\" title=\"Events and Presentations\">Events and Presentations<\/a>\u201d page under the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K8_ey9XLajFIEHB-bmAhVuBHNj0lBP4y3n2ixeWlG3R69xnNGtN68suXis7Dk2ikSS8zV3s10Z6xFRQRaH7rgIQTVPjmHcm4GwXDGY8ac7k=\" rel=\"nofollow\" target=\"_blank\" title=\"Investors + Media\">Investors + Media<\/a>\u201d section of the company\u2019s website. A replay of the webcasts will be available for 90 days.<\/p>\n<p><strong>About Praxis<\/strong>\u202f\u00a0<br \/>Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum&#x2122;, and antisense oligonucleotide (ASO) platform, Solidus&#x2122;, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across movement disorders and epilepsy, with four clinical-stage product candidates. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xbyk3aPPQ1XPaEHrpBi3kbLjRWhzEc1CtZ1nv7Fn-8azTgCWw0fcI4R8e6jC0iLMCKSKvPFnYf7LLyW9e4s6_Mu1V98mvV7ZPl9_unSk9cZZmjlhY0_hZXFtpQA1mfdUhIdj0dbEdOezpLJ4qVvmM8gy3f_Q27VONZAjmPSQUL7TWhylfSUXgzMVNS1cX2O93g_JCSA3EnZmS4ul_Y81Gk271BqVCNSUMPlx2Vv8XVDLNCOnKep3ZRqwm91uCtrV9BFpF1xRMg0RyICv6cpP0BLVeepKfszkDqf6HDMOVrHN-EyIPRMQgvvrZuwrKQ2ppwFXwlSCt9Jlv15cs2QqvgnLv2Rz7L8O9ISWdkl9AOwWWzb_5x5F7vb_KPIfnLwy1zsQtPo1AzfkFQrQ90FoYGcYRh37Ij2N5MYIIWfTbkjvg0wRCBpmSOuhGPu-d4CdUxB--IUkeng-eofPNjeGxh29C0ksvc_qDV2w3wPcewjIlZyEGB6EgiB7Qfgsn_-3\" rel=\"nofollow\" target=\"_blank\" title=\"www.praxismedicines.com\">www.praxismedicines.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UaPdQgCiKZuzCY_vattV_Dx5kDA6owc3-LX9OusV0igBhotjneqLWS2Me-jQDbe3fb3ta7-UEX9qyL-PO_cQGgz6uGQwSlbbeRo9PahmjKrrHw3aeLdRZqEmVfal-Ge_2733eHj-evmszz7ki2Grqw4fkeh15ceZBRkq_9caP7AHe4snE0SZEdQU-15EZXT0n0lCky4kEEMLth02TC1JinK08HRoALwDKbMn2qIV3ayB9_JhVsSnAQ9MYOEU_6aIEW-dabjsLUZq5z4TQmaemwz4jfw9axVpSnHnD_oNm57P5S3IzcmzrtVVARn_K-hPvNfGipF5IuKnF3iXv_8Zce4sjmZ2iDh-609YhU7DVkMxLzr_tbqV_3hhQGmwEokZ5QRM09In1wi4z5qpkx77kBECKZV-K5RTXTM48mhlPPf38tU9D7zNJ8JqRpsNlv0exltkTmVDOyRiNRissokEFG1-NZLAVaHIMs_stbDlvKw=\" rel=\"nofollow\" target=\"_blank\" title=\"Facebook\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bybIpY37djKUWdQe7fZodPFiLxmTXVdo23vnSsDfShUfGLwk4phU7c5vIHsoo-UOaKmQPDIID-Y6sEPCGfQA1eHf8iUKH_0puphIJJEPlttpsNqsuOmgRM_niOd34Dgm59R20SnTxBEVLUFWRZNFoqk1RFZKWqusX-tL6cKbYMXJlQjP97cW_loEYAJFgP6VZZ0J6U5Ij8W5Yt8ezkUqoDDT6LSe5-h9WgZ-72cR_-9tH7Of7-VGYhbogbRYcwR5hlgdH7NgR6_gmFNGM-v6I6aRjpDzrCDlciRIxiJL_iXnT0yQnZxws1d95bYCK-nP-SMkHClaiU1pUWg2g09Da9hNk1Nr78N1eUC5dv7Plmz2BZvSNZcRiQhkGP2jKgb3ipHIeMIFZ8xbzR7VnKBmfFUALCz3aG-8lMU_kY1M2wb18gZ6KfcOnprYuAU2NsRR8c-cwjIoPYV5U5K6TKeKrV_zSJlTcPDIwRG8IOFNr1jrikEV4iXE0nATwlU-lTCcZ0DZUZrk5k2oeieYy5IYCQ==\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fLgLuvr5P3b2pWmietvQog0a_C26r5CKhIDa39f6KPaJpuRMMx5Vihul6FD1Q_tYTAEOY_TZL99MdA6pA6sFJO6E9xap4rZ4VwhCUm2qavJhfhr94V1E-M4IGYzjsDesoURbuaXFhXybtzWn9q5rnez1T7Toa3n7PajZ4Uye3CRq4WU-qeyJZjJwYphcTH42c1E2TVbgeYbNYqIbofIMPptQp0svHWHR3xn70XNCTPD9w9SVKKPfrQE425tqrWP5zT0a0yMwSqQQn0dSX4Q8AgyomTDqUS3YdnGQ-WNmr4ZtuT2YPyt3GR7AaUQNq7ObINgRjwZp5JWQvheKcEhaQD6-r5gIvD5rVLHlAEc_XlsYFxP8cABhy0N8T_-knE1Tjb4lVCNfA83D8OobTrvZbbj_C_y3yXzQLh6E5nX8zMMGOhBWN-p80Y9NoRDSWgrZ\" rel=\"nofollow\" target=\"_blank\" title=\"Twitter\/X\">Twitter\/X<\/a>.<\/p>\n<pre>CONTACT: Investor Contact:\u00a0\r\nPraxis Precision Medicines\u00a0\r\ninvestors@praxismedicines.com\u00a0\r\n857-702-9452\u00a0\r\n\u00a0\r\nMedia Contact:\r\nDan Ferry\r\nLife Science Advisors\r\nDaniel@lifesciadvisors.com\r\n617-430-7576<\/pre>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGFkZGRkOGYtOGMwMC00N2Q1LTljMTktNTQ2YTI2MjdmM2Q0LTEyMTI0NDk=\/tiny\/Praxis-Precision-Medicines-Inc.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in two upcoming investor conferences: Praxis management will be participating in a [&#8230;]\n","protected":false},"author":1,"featured_media":64288,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64287","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Praxis Precision Medicines to Present at Two February Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Praxis Precision Medicines to Present at Two February Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-04T00:01:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Praxis-Precision-Medicines-Inc.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Praxis Precision Medicines to Present at Two February Investor Conferences\",\"datePublished\":\"2025-02-04T00:01:33+00:00\",\"dateModified\":\"2025-02-04T00:01:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/\"},\"wordCount\":306,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/\",\"name\":\"Praxis Precision Medicines to Present at Two February Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-04T00:01:33+00:00\",\"dateModified\":\"2025-02-04T00:01:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Praxis Precision Medicines to Present at Two February Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Praxis Precision Medicines to Present at Two February Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Praxis Precision Medicines to Present at Two February Investor Conferences","og_description":"BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) &#8212; Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating","og_url":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-04T00:01:33+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Praxis-Precision-Medicines-Inc.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Praxis Precision Medicines to Present at Two February Investor Conferences","datePublished":"2025-02-04T00:01:33+00:00","dateModified":"2025-02-04T00:01:33+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/"},"wordCount":306,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/","name":"Praxis Precision Medicines to Present at Two February Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-04T00:01:33+00:00","dateModified":"2025-02-04T00:01:33+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/praxis-precision-medicines-to-present-at-two-february-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Praxis Precision Medicines to Present at Two February Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64287"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64287\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64288"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}